BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 14714182)

  • 1. Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany.
    Hoffmann GF; von Kries R; Klose D; Lindner M; Schulze A; Muntau AC; Röschinger W; Liebl B; Mayatepek E; Roscher AA
    Eur J Pediatr; 2004 Feb; 163(2):76-80. PubMed ID: 14714182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and short-term outcome of children with symptomatic presentation of organic acid and fatty acid oxidation disorders in Germany.
    Klose DA; Kölker S; Heinrich B; Prietsch V; Mayatepek E; von Kries R; Hoffmann GF
    Pediatrics; 2002 Dec; 110(6):1204-11. PubMed ID: 12456920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience.
    Karam PE; Habbal MZ; Mikati MA; Zaatari GE; Cortas NK; Daher RT
    Clin Biochem; 2013 Dec; 46(18):1787-92. PubMed ID: 23994778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.
    Zytkovicz TH; Fitzgerald EF; Marsden D; Larson CA; Shih VE; Johnson DM; Strauss AW; Comeau AM; Eaton RB; Grady GF
    Clin Chem; 2001 Nov; 47(11):1945-55. PubMed ID: 11673361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Newborn Screening Program in the Community of Madrid: evaluation of positive cases.].
    Cambra Conejero A; Martínez Figueras L; Ortiz Temprado A; Blanco Soto P; Martín Rivada Á; Palomino Pérez L; Cañedo Villarroya E; Pedrón Giner C; Quijada Fraile P; Martín-Hernández E; García Silva MT; Chumillas Calzada S; Bellusci M; Belanger-Quintana A; Stanescu S; Martínez-Pardo Casanova M; Moráis López A; Bergua Martínez A; Ruiz-Salas P; Pérez González B; Ugarte M; Ruano MLF
    Rev Esp Salud Publica; 2020 Dec; 94():. PubMed ID: 33372917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.
    Schulze A; Lindner M; Kohlmüller D; Olgemöller K; Mayatepek E; Hoffmann GF
    Pediatrics; 2003 Jun; 111(6 Pt 1):1399-406. PubMed ID: 12777559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases.
    Moorthie S; Cameron L; Sagoo GS; Bonham JR; Burton H
    J Inherit Metab Dis; 2014 Nov; 37(6):889-98. PubMed ID: 25022222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expanded newborn screening in the Region of Murcia, Spain. Three-years experience].
    Juan-Fita MJ; Egea-Mellado JM; González-Gallego I; Moya-Quiles MR; Fernández-Sánchez A
    Med Clin (Barc); 2012 Dec; 139(13):566-71. PubMed ID: 22137990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
    Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
    Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feature construction can improve diagnostic criteria for high-dimensional metabolic data in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency.
    Ho S; Lukacs Z; Hoffmann GF; Lindner M; Wetter T
    Clin Chem; 2007 Jul; 53(7):1330-7. PubMed ID: 17513288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Newborn screening in France: news and perspectives].
    Gernez E; Roland E; Dhaenens CM; Renom G; Mention K
    Ann Biol Clin (Paris); 2024 Apr; 82(1):24-31. PubMed ID: 38638016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
    Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA
    Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency.
    Maier EM; Liebl B; Röschinger W; Nennstiel-Ratzel U; Fingerhut R; Olgemöller B; Busch U; Krone N; v Kries R; Roscher AA
    Hum Mutat; 2005 May; 25(5):443-52. PubMed ID: 15832312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCAD deficiency in Denmark.
    Andresen BS; Lund AM; Hougaard DM; Christensen E; Gahrn B; Christensen M; Bross P; Vested A; Simonsen H; Skogstrand K; Olpin S; Brandt NJ; Skovby F; Nørgaard-Pedersen B; Gregersen N
    Mol Genet Metab; 2012 Jun; 106(2):175-88. PubMed ID: 22542437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data mining methods for classification of Medium-Chain Acyl-CoA dehydrogenase deficiency (MCADD) using non-derivatized tandem MS neonatal screening data.
    Van den Bulcke T; Vanden Broucke P; Van Hoof V; Wouters K; Vanden Broucke S; Smits G; Smits E; Proesmans S; Van Genechten T; Eyskens F
    J Biomed Inform; 2011 Apr; 44(2):319-25. PubMed ID: 21167313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany.
    Lindner M; Gramer G; Haege G; Fang-Hoffmann J; Schwab KO; Tacke U; Trefz FK; Mengel E; Wendel U; Leichsenring M; Burgard P; Hoffmann GF
    Orphanet J Rare Dis; 2011 Jun; 6():44. PubMed ID: 21689452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tandem spectrometry in newborn screening.
    Seashore MR
    Curr Opin Pediatr; 1998 Dec; 10(6):609-14. PubMed ID: 9848021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening.
    Yusupov R; Finegold DN; Naylor EW; Sahai I; Waisbren S; Levy HL
    Mol Genet Metab; 2010 Sep; 101(1):33-9. PubMed ID: 20580581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan.
    Niu DM; Chien YH; Chiang CC; Ho HC; Hwu WL; Kao SM; Chiang SH; Kao CH; Liu TT; Chiang H; Hsiao KJ
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S295-305. PubMed ID: 20567911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
    Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
    PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.